Aditi Jain

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (4)

• Correction: Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms
  Oncogene 2025 DOI: 10.1038/s41388-025-03364-6
  +Save
• Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms
  Oncogene 2025 DOI: 10.1038/s41388-024-03227-6
  +Save
• The Relationship Between Response Rate and Survival Benefits in Randomized Immunotherapy Studies
  Cancers 2025 DOI: 10.3390/cancers17030495
  +Save
• A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabete…
  Diabetes Therapy 2024 DOI: 10.1007/s13300-023-01504-3
  +Save